From: Predicting new molecular targets for rhein using network pharmacology
GeneID Entry | Gene name | Disease | Pathway |
---|---|---|---|
4313 | MMP2 | Cancer | GnRH signaling pathway |
 |  | Choriocarcinoma | Leukocyte transendothelial migration |
 |  | Torg-Winchester syndrome | Pathways in cancer |
4318 | MMP9 | Penile cancer | Pathways in cancer |
 |  | Metaphyseal dysplasias | Leukocyte transendothelial migration |
 |  |  | Transcriptional misregulation in cancer |
7124 | TNF | Asthma | MAPK signaling pathway |
 |  | Systemic lupus erythematosus | Cytokine-cytokine receptor interaction |
 |  | Malaria | Natural killer cell mediated cytotoxicity |
 |  | Pertussis | NOD-like receptor signaling pathway |
 |  | Type I, II diabetes mellitus | Toll-like receptor signaling pathway |
 |  | Alzheimer's disease | RIG-I-like receptor signaling pathway |
 |  | Amoebiasis | Natural killer cell mediated cytotoxicity |
 |  | Tuberculosis | T cell receptor signaling pathway |
 |  | Hepatitis C | Fc epsilon RI signaling pathway |
 |  | Influenza A | Apoptosis |
 |  | HTLV-I infection | TGF-beta signaling pathway |
 |  | Herpes simplex infection | Natural killer cell mediated cytotoxicity |
 |  | Cardiovascular Diseases; | Hematopoietic cell lineage |